ArticleFrontiers in aging2026
Integrating evolutionary theory into a framework for the mechanistic evaluation of candidate anti-aging interventions.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite decades of research into the molecular hallmarks of aging, geroscience lacks a unifying framework that both coherently integrates evolutionary accounts of aging and is directly useful for intervention assessment. Here, we propose the 'Aging Onion', a layered, two-axis framework developed to help interpret the diversity of phenotypes associated with aging, and informed by the mechanistic emphases foregrounded by the Disposable Soma and Hyperfunction traditions. In this framework, persistent activity of growth and developmental programmes, alongside insufficient somatic maintenance, define two broad biological axes through which we attempt to interpret age-related degeneration, and intervention responses. To examine the utility of this framework, we focus on nutrient sensing as an initial benchmark domain. Within this space, caloric restriction is a conserved reference intervention, while rapamycin provides a narrower pharmacological comparator acting primarily through TOR-centred signalling. We ask whether the proposed axes of the Aging Onion can help ground the mechanistic divergence between these interventions in aging-relevant biology and thereby interpret their differing efficacies. We conclude by outlining future directions for testing whether this framework can be operationalised in broader intervention assessment, and for determining whether its layered logic generalises beyond nutrient sensing to other domains of aging biology, including population-genetics approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.